Viral Hepatitler

Hepatit B, C ve D virüs enfeksiyonlarının tedavisi, direnç mekanizmaları ve uzun dönem izlemi üzerine yayınlar.

58 publications

• The association with histopathological findings and predictive significance of transforming growth factor beta 1 (TGF Β1) in patients with chronic viral hepatitis

  MS Bugdaci, C Karaca, AR Koksal, S Boga, C Alkim, M Sokmen

  Archives of Hepatitis Research 9 (1), 5-10 · 2023 · 2 atıf

• Can Interferon Therapy Change the Natural Course of Hepatitis Delta Infection?: a Clinical and Pathological Study

  OK Bakkaloglu, O Yildirim, B Cavus, S Evirgen, S Gokturk, A Ormeci, ...

  Antimicrobial agents and chemotherapy 66 (1), e01586-21 · 2022 · 2 atıf

• OĞUZ KAĞAN BAKKALOĞLU

  Ç KARACA

  A Clinical Guide to the Treatment of Viral Hepatitis, 62 · 2022

• Evaluation of safety and efficacy of tenofovir disoproxil in hemodialysis and renal transplant patients monoinfected with hepatitis B virus based on real life data

  F Akyüz, B Çavuş, N Nizam, S Göktürk, B Baran, S Evirgen, Ü Akyüz, ...

  Clinical and experimental hepatology 8 (1), 7-13 · 2022

• Changing epidemiology of chronic hepatitis C: patients are older and at a more advanced stage at the time of diagnosis

  R Iliaz, T Yuce, S Torun, B Cavus, M Gulluoglu, M Bozaci, C Karaca, ...

  European Journal of Gastroenterology & Hepatology 31 (10), 1247-1249 · 2019 · 7 atıf

• Extrahepatic manifestations of hepatitis C virus infection

  Ç Karaca

  Viral hepatitis: chronic hepatitis C, 183-195 · 2019 · 1 atıf

• Prevention of mother-to-child transmission of HBV

  N Karaca, Ç Karaca

  Viral Hepatitis: Chronic Hepatitis B, 65-70 · 2018 · 1 atıf

• Predictors of treatment requirement in HBeAg-negative chronic hepatitis B patients with persistently normal alanine aminotransferase and high serum HBV DNA levels

  A Ormeci, Y Aydın, A Sumnu, B Baran, OM Soyer, B Pınarbasi, S Gokturk, ...

  International Journal of Infectious Diseases 52, 68-73 · 2016 · 44 atıf

• Comparison of the efficacy of 12 months and longer courses of interferon therapy for the treatment of chronic delta hepatitis: a retrospective cohort study

  OM Soyer, B Baran, AC Ormeci, S Gokturk, E Aydın, D Onel, M Gulluoglu, ...

  Postgraduate medicine 128 (4), 432-438 · 2016 · 12 atıf

• Differences in nephrotoxicity risk and renal effects among anti‐viral therapies against hepatitis B

  S Koklu, MT Gulsen, Y Tuna, H Koklu, O Yuksel, M Demir, R Guner, ...

  Alimentary pharmacology & therapeutics 41 (3), 310-319 · 2015 · 63 atıf

• Tenofovir disoproxil fumarate has a substantial efficacy against multidrug‐resistant strains of hepatitis B virus

  B Baran, OM Soyer, AC Ormeci, S Gokturk, S Evirgen, F Akyuz, C Karaca, ...

  Liver International 35 (10), 2265-2274 · 2015 · 5 atıf

• Effects of polymorphisms in interferon λ 3 (interleukin 28B) on sustained virologic response to therapy in patients with chronic hepatitis D virus infection

  E Yilmaz, B Baran, OM Soyer, M Onel, D Onel, AC Ormeci, S Gokturk, ...

  Clinical Gastroenterology and Hepatology 12 (10), 1753-1758 · 2014 · 23 atıf

• Treatment failure may lead to accelerated fibrosis progression in patients with chronic hepatitis C

  B Baran, M Gulluoglu, OM Soyer, AC Ormeci, S Gokturk, S Evirgen, ...

  Journal of viral hepatitis 21 (2), 111-120 · 2014 · 22 atıf

• Routinely evaluated clinical assays and laboratory tests [real test] and fibrosis stages of chronic hepatitis B and C

  MS Buğdacı, H Korkmaz, A Demir, M Bıyık, T Temel, HS Göktürk, ...

  Turkish Journal of Gastroenterology 25 (5), 539-545 · 2014 · 2 atıf

• P1046 ENTECAVIR AND TENOFOVIR HAVE A COMPARABLE EFFICACY IN TREATMENT OF NUCLEOS (T) IDE ANALOGUE NAIVE PATIENTS WITH CHRONIC HEPATITIS B: A REAL LIFE EXPERIENCE

  B Baran, OM Soyer, AC Ormeci, S Gokturk, S Evirgen, F Akyuz, C Karaca, ...

  Journal of Hepatology 1 (60), S424 · 2014

• Foro Hepatitis C Foros de Auto Ayuda de Hepatitis C

  B Baran, M Gulluoglu, OM Soyer, AC Ormeci, S Gokturk, S Evirgen, ...

  J Viral Hepat 21 (2), 111-120 · 2014

• Efficacy of tenofovir in patients with Lamivudine failure is not different from that in nucleoside/nucleotide analogue-naive patients with chronic hepatitis B

  B Baran, OM Soyer, AC Ormeci, S Gokturk, S Evirgen, HU Bozbey, ...

  Antimicrobial agents and chemotherapy 57 (4), 1790-1796 · 2013 · 63 atıf

• Efficacy of pegylated interferon-α treatment for 24 months in chronic delta hepatitis and predictors of response

  C Karaca, OM Soyer, B Baran, AC Ormeci, S Gokturk, E Aydin, S Evirgen, ...

  Antivir Ther 18 (4), 561-6 · 2013 · 51 atıf

• Lamivudine treatment failure risks in chronic hepatitis B patients with low viral load

  S Koklu, MT Gulsen, Y Tuna, H Koklu, O Yuksel, B Yilmaz, C Karaca, ...

  Digestion 88 (4), 266-271 · 2013 · 3 atıf

• Risk factors for significant liver fibrosis in genotype D HBeAg-negative chronic hepatitis B infection with persistently normal ALT and high serum HBVDNA levels: 1039

  AC Ormeci, F Akyuz, B Baran, OM Soyer, S Gokturk, C Karaca, ...

  Hepatology 58, 709A · 2013 · 1 atıf

• Virological Supression Does not Prevent the Development of Hepatocellular Carsinoma in Cirrhotic Patients with Genotype D Hepatitis B Infection: 990

  S Gokturk, R Basar, AR Ucar, BH Basgoze, M Altinkaynak, P Buyukballi, ...

  Hepatology 58, 684A-685A · 2013 · 1 atıf

• Safety of Tenofovir in Renal Transplanted and Hemodialysis Patients with Chronic Hepatitis B: 1016

  F Akyuz, S Gokturk, B Baran, A Ormeci, OM Soyer, S Evirgen, C Karaca, ...

  Hepatology 58, 698A · 2013

• The antiviral efficacy of entecavir is not influenced by prior treatment with nucleos (t) ide analogues in patients with chronic hepatitis B: 1012

  B Baran, OM Soyer, AC Ormeci, S Gokturk, S Evirgen, F Akyuz, C Karaca, ...

  Hepatology 58, 695A-696A · 2013

• Tenofovir disoproxil fumarate has a substantial efficacy against adefovir and multi-drug resistant strains of hepatitis B virus: 1017

  B Baran, OM Soyer, AC Ormeci, S Gokturk, S Evirgen, F Akyuz, C Karaca, ...

  Hepatology 58, 698A-699A · 2013

• Sa1013 IL28B Polymorphisms and Influence on Sustained Virological Response to Interferon Therapy in Chronic DELTA Hepatitis

  C Karaca, E Yilmaz, OM Soyer, D Onel, M Onel, B Baran, A Ormeci, ...

  Gastroenterology 5 (144), S-972 · 2013

• Serum complement C4 in chronic hepatitis C: correlation with histopathologic findings and disease activity

  MS Buğdaci, C Karaca, C Alkim, B KESİCİ, B Bayraktar, M Sökmen

  Turkish Journal of Gastroenterology 23 (1), 33-37 · 2012 · 13 atıf

• Response to tenofovir treatment of treatment-naive and adefovir experienced patients with chronic hepatitis b: 412

  O Keskin, AC Ormeci, G Kabacam, F Akyuz, H Aniktar, C Karaca, ...

  Hepatology 56, 394A-395A · 2012

• 520 RESPONSE TO TENOFOVIR TREATMENT OF TREATMENT-NAIVE VS ADEFOVIR-RESISTANT VS SUBOPTIMAL RESPONDER PATIENTS WITH CHRONIC HEPATITIS B

  O Keskin, A Ormeci, G Kabacam, F Akyuz, H Aniktar, C Karaca, R Idilman, ...

  Journal of Hepatology 56, S206 · 2012

• Could complement C4 be an alternative to biopsy for chronic hepatitis B histopathologic findings?

  MS Bugdaci, C Alkim, C Karaca, B Kesici, B Bayraktar, M Sokmen

  Journal of clinical gastroenterology 45 (5), 449-455 · 2011 · 21 atıf

• A rare complication of interferon treatment: optic neuropathy

  S Gokturk, K Atay, A Ormeci, B Baran, OM Soyer, F Akyuz, C Karaca, ...

  Annals of Gastroenterology: Quarterly Publication of the Hellenic Society of … · 2011 · 3 atıf

• Kronik viral hepatitlerde fibrozis göstergesi olarak non invaziv testlerin değerlendirilmesi

  Z Aydın

  Journal of Istanbul Faculty of Medicine 66 (3) · 2011 · 2 atıf

• Comments on Histologic Predictors of Fibrosis Progression in Posttransplant Hepatitis C Recurrence

  B Baran, C Karaca, F Akyuz

  Clinical Gastroenterology and Hepatology 8 (8), 735-736 · 2010

• Comments on Histologic Predictors of Fibrosis Progression in Posttransplant Hepatitis C Recurrence. Authors' reply

  B ULENT BARAN, C KARACA, F AKYUZ, EE FURTH, RG WELLS

  Clinical gastroenterology and hepatology 8 (8), 735-736 · 2010

• Is HCV genotyping cost-effective even when the prevalences of genotypes 2 and 3 are low

  V Tahan, R Ozaras, C Karaca, S Uraz, F Eren, A Danalioglu, E Avsar, ...

  Hepatogastroenterology 56 (94-95), 1425-8 · 2009 · 6 atıf

• Lamivudine monotherapy and lamivudine plus interferon alpha combination therapy in HBeAg negative chronic hepatitis B not responding to previous interferon alpha monotherapy.

  F Akyuz, S Kaymakoglu, K Demir, N Aksoy, C Karaca, A Danalioglu, ...

  Acta Gastro-Enterologica Belgica 70 (1) · 2007 · 15 atıf

• Long-term results of interferon alpha monotherapy in patients with HBeAg-negative chronic hepatitis B

  S Kaymakoglu, A Danalioglu, K Demir, C Karaca, F Akyuz, D Onel, ...

  Digestive diseases and sciences 52 (3), 727-731 · 2007 · 4 atıf

• Ülkemizdeki hepatit D virus genotipi

  Ç Karaca, M Bozacı, F Akyüz, K Demir, F Beşışık, Y Çakaloğlu, S Badur, ...

  Akademik Gastroenteroloji Dergisi 6 (2), 76-77 · 2007

• Risk factors for the transmission of hepatitis C virus infection in the Turkish population

  Ç Karaca, Y Çakaloğlu, K Demir, S Özdil, S Kaymakoğlu, S Badur, ...

  Digestive diseases and sciences 51 (2), 365-369 · 2006 · 86 atıf

• Sexual transmission of HCV between spouses

  V Tahan, C Karaca, B Yildirim, A Bozbas, R Ozaras, K Demir, E Avsar, ...

  American Journal of Gastroenterology 100 (4), 821-824 · 2005 · 197 atıf

• Alpha interferon and ribavirin combination therapy of chronic hepatitis D

  S Kaymakoglu, C Karaca, K Demir, S Poturoglu, A Danalioglu, S Badur, ...

  Antimicrobial agents and chemotherapy 49 (3), 1135-1138 · 2005 · 55 atıf

• Ribavirin treatment in patients with chronic hepatitis C infection who had renal transplantation

  C Karaca, F Besisik, F Akyuz, D Dincer, MS Sever, A Okten

  Digestive Surgery 22 (1-2), 113 · 2005 · 4 atıf

• Efficacy of alpha interferon therapy for lamivudine resistance in chronic hepatitis B

  A Danalioglu, S Kaymakoglu, Y Cakaloglu, K Demir, C Karaca, ...

  International journal of clinical practice 58 (7), 659-661 · 2004 · 24 atıf

• Hepatit C virus infeksiyonlu hastalarda hepatit B virus sıklığı

  Ç Karaca, Y Çakaloğlu, K Demir, S Özdil, S Kaymakoğlu, S Badur, ...

  Akademik Gastroenteroloji Dergisi 3 (2) · 2004 · 4 atıf

• The frequency of hepatitis B Virus in patients with hepatitis C virus

  Ç Karaca, Y Çakaloğlu, K Demir, S Özdil, S Kaymakoğlu, S Badur, ...

  Akademik Gastroenteroloji Dergisi 3, 76-78 · 2004 · 2 atıf

• Occult HBV infection and YMDD variants in hemodialysis patients with chronic HCV infection

  F Besisik, C Karaca, F Akyüz, S Horosanlı, D Önel, S Badur, MŞ Sever, ...

  Journal of hepatology 38 (4), 506-510 · 2003 · 140 atıf

• Gebe popülasyonunda hepatit B, C, D virus infeksiyonu sıklığı ve hepatit C virusunun perinatal yolla geçiş oranı

  Ç Karaca, N Karaca, T Usta, K Demir, S Kaymakoğlu, F Beşışık, B Sıdal, ...

  Akademik Gastroenteroloji Dergisi 2 (3), 122-124 · 2003 · 29 atıf

• Lamivudine treatment in patients with hepatitis B virus induced liver cirrhosis.

  K Cetin, K Sabahattin, D Kadir, D Ahmet, D Ziyaettin, B Selim, B Mürüvvet, ...

  Hepato-gastroenterology 50, ccxcv-ccxcvii · 2003 · 3 atıf

• Are there any noninvasive markers for diagnosis of viral hepatitis?

  Z Aydin, K Demir, A Okten, S Kaymakoglu, N Salmayenli, S Ozdil, ...

  Journal of Hepatology 38, 110 · 2003

• Time to development of chronic liver diseases in a genotype 1 dominant population of chronic hepatitis C virus infection

  C Karaca, Y Cakalogu, K Demir, S Ozdil, S Kaymakoglu, S Badur, ...

  Journal of Hepatology 38, 148-149 · 2003

• Autoimmune hepatitis; What factors predict the response to combination therapy of azathioprine plus steroid

  S Kaymakoglu, K Demir, A Danalioglu, F Akyuz, Z Durakoglu, C Karaca, ...

  Gastroenterology 124 (4), A786 · 2003

• The preliminary results of interferon alpha and ribavirin combination therapy in chronic delta hepatitis.

  C Karaca, A Dattalioglu, F Akyuz, K Demir, M Bozaci, S Turkoglu, S Badur, ...

  HEPATOLOGY 36 (4), 650A-650A · 2002

• Occult HBV infection and YMDD mutants in hemodialysis patients with chronic HCV infection.

  FS Besisik, C Karaca, F Akyuz, A Danalioglu, D Onel, K Demir, S Badur, ...

  HEPATOLOGY 36 (4), 613A-613A · 2002

• Long-term results of alpha interferon therapy in anti-HBe (+) chronic hepatitis B.

  S Kaymakoglu, K Demir, Y Cakaloglu, Z Durakoglu, C Karaca, ...

  HEPATOLOGY 34 (4), 621A-621A · 2001

• Lamivudine and alpha interferon combination therapy in patients with anti-HBE-positive chronic hepatitis B: preliminary results of a randomised study

  S Kaymakoglu, K Demir, Y Cakaloglu, Z Durakoglu, D Dincer, C Karaca, ...

  Journal of Hepatology 34, 171 · 2001

• Interferon alpha-2b plus ribavirin for chronic hepatitis C in primary nonresponders to interferon alone

  K Demir, S Kaymakoglu, D Dincer, I Tuncer, Z Durakoglu, C Karaca, ...

  Journal of Hepatology 34, 171 · 2001

• Long-term results of interferon treatment in hemodialysis patients with chronic C hepatitis

  D Dinçer, F Beşışık, MŞ Sever, Ç Karaca, R KAZANCIOĞLU, Y Çakaloğlu, ...

  Endoskopi Dergisi 12 · 2001

• Kronik Hepatit C'li Hastalar Artık Daha Yaşlı ve Daha Ciddi Karaciğer Hastalığı İle Kliniğe Başvuruyor

  R İLİAZ, T YÜCE İNEL, EGE TORUN, B ÇAVUŞ, M GÜLLÜOĞLU, ...

• KRONİK DELTA HEPATİTLİ HASTALARDA İNTERLÖKİN-28B GEN POLİMORFİZMİNİN İNTERFERON TEDAVİSİNE YANIT ÜZERİNE ETKİSİ

  E YILMAZ, Ç KARACA